Fast Five Quiz: Cardiovascular Disease Risk Management in Women

Yasmine S. Ali, MD


December 14, 2020

According to updated guidelines from the AHA and American College of Cardiology on the management of blood cholesterol, in addition to lifestyle changes, statins, fibrates, and omega-3 fatty acids can be considered for women 40-75 years of age with persistently elevated triglyceride levels and an atherosclerotic CVD risk ≥ 7.5%. Primary and secondary factors, such as obesity, metabolic syndrome, diabetes mellitus, hypothyroidism, and chronic kidney or liver disease, should be addressed in concert with treatment of the hypertriglyceridemia. Specific treatment recommendations vary according to moderate or high risk. These guidelines largely align with those from the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS), with modest differences in risk classification.

Women who smoke should be encouraged to stop at each visit and provided with counseling, nicotine replacement, and other pharmacotherapy as indicated in conjunction with a behavioral program or formal smoking cessation program.

At least 150 minutes of moderate exercise per week is recommended to help prevent CVD in women. Seventy-five minutes of vigorous exercise or an equivalent combination of moderate- and vigorous-intensity aerobic physical activity are acceptable alternatives.

Statin therapy is recommended in women ≥ 65 years of age with prior CVD who have adequate blood pressure control.

Learn more about CVD risk management.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.